(Q47575129)

English

First-time-in-human study of GSK923295, a novel antimitotic inhibitor of centromere-associated protein E (CENP-E), in patients with refractory cancer

scientific article published on 22 October 2011

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

4 February 2018

http://europepmc.org/abstract/MED/22020315

First-time-in-human study of GSK923295, a novel antimitotic inhibitor of centromere-associated protein E (CENP-E), in patients with refractory cancer (English)

1 reference

Europe PubMed Central

4 February 2018

http://europepmc.org/abstract/MED/22020315

author name string

Vincent Chung

1

1 reference

Europe PubMed Central

4 February 2018

http://europepmc.org/abstract/MED/22020315

Elisabeth I Heath

2

1 reference

Europe PubMed Central

4 February 2018

http://europepmc.org/abstract/MED/22020315

William R Schelman

3

1 reference

Europe PubMed Central

4 February 2018

http://europepmc.org/abstract/MED/22020315

Brendan M Johnson

4

1 reference

Europe PubMed Central

4 February 2018

http://europepmc.org/abstract/MED/22020315

Lyndon C Kirby

5

1 reference

Europe PubMed Central

4 February 2018

http://europepmc.org/abstract/MED/22020315

Kerlin M Lynch

6

1 reference

Europe PubMed Central

4 February 2018

http://europepmc.org/abstract/MED/22020315

Jeffrey D Botbyl

7

1 reference

Europe PubMed Central

4 February 2018

http://europepmc.org/abstract/MED/22020315

Thomas A Lampkin

8

1 reference

Europe PubMed Central

4 February 2018

http://europepmc.org/abstract/MED/22020315

Kyle D Holen

9

1 reference

Europe PubMed Central

4 February 2018

http://europepmc.org/abstract/MED/22020315

publication date

22 October 2011

1 reference

Europe PubMed Central

4 February 2018

http://europepmc.org/abstract/MED/22020315

Cancer Chemotherapy and Pharmacology

1 reference

Europe PubMed Central

4 February 2018

http://europepmc.org/abstract/MED/22020315

69

1 reference

Europe PubMed Central

4 February 2018

http://europepmc.org/abstract/MED/22020315

3

1 reference

Europe PubMed Central

4 February 2018

http://europepmc.org/abstract/MED/22020315

733-741

1 reference

Europe PubMed Central

4 February 2018

http://europepmc.org/abstract/MED/22020315

https://scigraph.springernature.com/pub.10.1007/s00280-011-1756-z

0 references

Development of new cancer therapeutic agents targeting mitosis

1 reference

https://api.crossref.org/works/10.1007%2FS00280-011-1756-Z

21 January 2018

Antitumor activity of an allosteric inhibitor of centromere-associated protein-E.

1 reference

https://api.crossref.org/works/10.1007%2FS00280-011-1756-Z

21 January 2018

The role of kinesin family proteins in tumorigenesis and progression: potential biomarkers and molecular targets for cancer therapy

1 reference

https://api.crossref.org/works/10.1007%2FS00280-011-1756-Z

21 January 2018

Targeting a kinetochore-associated motor protein to kill cancer cells

1 reference

https://api.crossref.org/works/10.1007%2FS00280-011-1756-Z

21 January 2018

Aneuploidy: instigator and inhibitor of tumorigenesis

1 reference

https://api.crossref.org/works/10.1007%2FS00280-011-1756-Z

21 January 2018

New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada

1 reference

https://api.crossref.org/works/10.1007%2FS00280-011-1756-Z

21 January 2018

Anemia in oncology practice: relation to diseases and their therapies

1 reference

https://api.crossref.org/works/10.1007%2FS00280-011-1756-Z

21 January 2018

Phase II study of the cyclin-dependent kinase inhibitor flavopiridol administered to patients with advanced gastric carcinoma.

1 reference

https://api.crossref.org/works/10.1007%2FS00280-011-1756-Z

21 January 2018

Kinesin motor proteins as targets for cancer therapy

1 reference

https://api.crossref.org/works/10.1007%2FS00280-011-1756-Z

21 January 2018

Targeted anti-mitotic therapies: can we improve on tubulin agents?

1 reference

https://api.crossref.org/works/10.1007%2FS00280-011-1756-Z

21 January 2018

Phase I and pharmacokinetic study of the novel oral cell-cycle inhibitor Ro 31-7453 in patients with advanced solid tumors

1 reference

https://api.crossref.org/works/10.1007%2FS00280-011-1756-Z

21 January 2018

Identifiers

10.1007/S00280-011-1756-Z

1 reference

Europe PubMed Central

4 February 2018

http://europepmc.org/abstract/MED/22020315

1 reference

Europe PubMed Central

4 February 2018

http://europepmc.org/abstract/MED/22020315

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q47575129&oldid=2160153579"